Kory James Wentworth, CFO: Entrada Therapeutics TRDA Sell · Filed 24/09/10

Trade details

Type: Insider sale
Amount: $47,829.15
Shares · price: 3,195 sh · $14.97 a share
Held after: 76,486 sh
Stock: Entrada Therapeutics TRDA
Person: Kory James WentworthCFO
Trade date: 24/09/09
Filed: 24/09/10
Days to filing: 1 days

Sold 4.0% of holdings

Share of holding sold: 4.0%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/10~24/10/09

Kory James Wentworth's recent trades

Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$32.4K
2,500 sh
$32.4K
Filed 04/02
Traded 04/01
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$31.6K
2,500 sh
$31.6K
Filed 04/01
Traded 04/01
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$148.3K
11,388 sh
$148.3K
Filed 03/11
Traded 03/10
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$66.2K
5,089 sh
$66.2K
Filed 03/11
Traded 03/09
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$207.3K
16,477 sh
$207.3K
Filed 03/09
Traded 03/09

Kory James Wentworth, CFO — sold $47.8K of Entrada Therapeutics TRDA · 4.0% of holdings · 10b5-1 plan | Whalegun